Companies › LMED

LMED 10-K & 10-Q changes, risk factors and insider trading

LataMed AI Corp. · OTC · Services-Computer Programming, Data Processing, Etc. · CIK 1477960 · All filings on SEC.gov

Everything below is quoted or computed from LataMed AI Corp.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

32 / 41risk-factor paragraphs added / removed in latest 10-K
12new risk-factor headings
0Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparing 10-K filed 2026-04-16 (period ending 2025-12-31) with 10-K filed 2025-04-23 (period ending 2024-12-31).

Risk Factors (10-K Item 1A)

32new paragraphs
41removed paragraphs
5reworded paragraphs
3,977 → 1,241words in section

New heading “We are a development-stage company with no revenue and a history of losses, and we may never achieve profitability.”

New heading “Our management team is small, and the loss of key personnel could adversely affect our business.”

New heading “Our controlling shareholder has significant voting power, which may not align with the interests of other shareholders.”

New heading “Our operating results may fluctuate significantly.”

New heading “Rapid technological change could render our technology obsolete or uncompetitive.”

New heading “Privacy laws, biometric regulations, and data protection requirements could limit adoption of our technology.”

New heading “Ethical concerns, algorithmic bias, and misuse of facial recognition technology could adversely affect our business.”

New heading “Our software is complex and may contain errors or vulnerabilities.”

New heading “We may be unable to adequately protect our intellectual property or may be subject to infringement claims.”

New heading “RISKS ASSOCIATED WITH OUR COMMON STOCK”

New heading “Our common stock is subject to the SEC’s “penny stock” rules, which may limit liquidity.”

New heading “Future issuances of common stock could dilute existing shareholders.”

Removed heading “We are a recently re-organized development stage company but have not yet commenced operations in our business. We expect to incur operating losses in the foreseeable future.”

Removed heading “We have incurred net losses since our inception and expect losses to continue.”

Removed heading “Our current president and chief executive officer may have other business interests.”

Removed heading “Our officers and directors control approximately 66.53% of the Company, giving them significant voting power, which allows them to take actions that may not be in the best interest of all other shareholders.”

Removed heading “We have requirements for and there is an uncertainty of access to additional capital.”

Removed heading “Privacy concerns, evolving regulation of artificial intelligence, facial recognition and use of biometrics, and other domestic or foreign regulations may limit the use and adoption of our solutions and services and adversely affect our business.”

Removed heading “We will need continual development of our products to adapt to rapidly changing technology and consumer demands.”

Removed heading “Our software is highly complex and may contain undetected errors.”

Removed heading “We are subject to the terms of open-source licenses because our technology will incorporate open-source software.”

Removed heading “We may be subject to intellectual property claims, which are extremely costly to defend, could require us to pay significant damages and could limit our ability to use certain technologies in the future.”

Removed heading “Ethical Use of AI in Facial Recognition.”

Removed heading “Risk of Racial Bias in AI and Biometric Technology.”

Removed heading “RISKS ASSOCIATED WITH THIS REGISTRATION STATEMENT”

Removed heading “Our common stock is subject to the “penny stock” rules of the Securities and Exchange Commission, and the trading market in our securities is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: litigation, fine, penalt, regulation
“Failure to comply with applicable laws and regulations could result in fines, penalties, litigation, reputational harm, or limitations on our ability to operate in certain jurisdictions.”
see in full comparison
Removed text topics: fine, penalt, regulation
“Regulation related to the provision of services over involving AI, facial recognition and use of biometrics is evolving, as federal, state, and foreign governments continue to adopt new, or modify existing, laws and regulations addressing data privacy and the collection, processing, storage, transfer, and use of data. …”
see in full comparison
Removed text topics: artificial intelligence, regulation
“Privacy concerns, evolving regulation of artificial intelligence, facial recognition and use of biometrics, and other domestic or foreign regulations may limit the use and adoption of our solutions and services and adversely affect our business.”
see in full comparison
Removed text topics: securities and exchange commission
“Our common stock is subject to the “penny stock” rules of the Securities and Exchange Commission, and the trading market in our securities is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.”
see in full comparison
New text topics: liquidity
“Our common stock is subject to the SEC’s “penny stock” rules, which may limit liquidity.”
see in full comparison
New text topics: regulation
“Privacy laws, biometric regulations, and data protection requirements could limit adoption of our technology.”
see in full comparison
Full comparison: every changed paragraph (78)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, astogether well aswith the other information contained in this Annual Report, including our financial statements and the related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” before decidingmaking whetheran toinvestment investdecision. in our securities. The occurrence ofIf any of the eventsfollowing orrisks developments described below could harmoccur, our business, financial condition, operatingresults results,of operations, and growthprospects prospects.could be materially and adversely affected. In such an event, the market price of our common stock could decline, and you maycould lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations.

Added

We are a development-stage company with no revenue and a history of losses, and we may never achieve profitability.

Added

We are a development-stage technology company and have not yet generated revenue from operations. Since inception, we have incurred net losses and expect to continue to incur losses for the foreseeable future as we continue to develop our facial recognition technology and related business operations. We have a limited operating history upon which to evaluate our business prospects, and there can be no assurance that our development efforts will result in commercially viable products or services.

Added

Prior to commercialization, we expect to incur increased operating expenses without corresponding revenues. If we are unable to successfully develop, commercialize, and market our technology, or if market acceptance does not occur, our business may fail and investors could lose their entire investment.

Removed

We are a recently re-organized development stage company but have not yet commenced operations in our business. We expect to incur operating losses in the foreseeable future.

Removed

We were incorporated on September 11, 2008, and ceased all operations in 2016. To date, the Company has been involved primarily in re-organization activities. Until March 20, 2023, we had limited to no operations, and we have only recently commenced our business operations, including a shift in focus from Big Data to FRT in June 2024 Accordingly, we have no way to evaluate the likelihood that our business will be successful. The likelihood of success must be considered in light of the problems, expenses, difficulties, complications and delays encountered in connection with the operations that we may undertake in the future. These potential problems include, but are not limited to, unanticipated problems relating to the market acceptance of our business, developing relationship with suppliers, distribution and challenges, and additional costs and expenses that may exceed current estimates. Prior to the time that we are ready to market and distribute our prospective product line, we anticipate that the Company will incur increased operating expenses without realizing any revenues. We expect to incur significant losses in the foreseeable future and recognize that if the effectiveness of our business plan is not forthcoming, we will not be able to continue business operations. There is no operating history upon which to base any assumption as to the likelihood that we will prove successful, and it is doubtful that we will generate any operating revenues or ever achieve profitable operations. If we are unsuccessful in addressing these risks, our yet to be determined acquisition of business or assets and subsequent business operations will most likely fail.

Removed

We have incurred net losses since our inception and expect losses to continue.

Removed

We have not been profitable since our inception and there is no guarantee that our subsequent operations will be profitable in the future. Subsequently, you could lose your entire investment.

Added

Our independent registered public accounting firm has issued an audit report expressing substantial doubt about our ability to continue as a going concern. Our ability to continue operations is dependent upon obtaining additional financing through equity offerings, debt financings, shareholder support, or other sources.

Added

There can be no assurance that additional financing will be available when needed, in sufficient amounts, or on acceptable terms. If we are unable to obtain additional capital, we may be required to delay, scale back, or discontinue our development activities, which would have a material adverse effect on our business.

Removed

Our independent accountant’s audit report states that we have incurred only losses since our inception, raising substantial doubt about our ability to continue as a going concern. Therefore, our ability to continue as a going concern is highly dependent upon obtaining additional financing for our planned operations. There can be no assurance that we will be able to raise any additional funds, neither are we able to raise additional funds, nor that such funds will be in the amounts required or on terms favorable to us.

Removed

Our current president and chief executive officer may have other business interests.

Removed

Mr. Waqas Nakhwa, our President and Chief Executive Officer, currently devotes approximately 30+ hours per week. While he presently possesses adequate time to attend to our interest, it is possible that the demands on him from other obligations could increase, with the result that he would no longer be able to devote sufficient time to the management of our business. The loss of Mr. Nakhwa to our company could negatively impact our business development.

Removed

Our officers and directors control approximately 66.53% of the Company, giving them significant voting power, which allows them to take actions that may not be in the best interest of all other shareholders.

Removed

Mr. Nakhwa, our President, Chief Executive Officer, and a member of our Board of Directors, owns approximately 66.5% of our current outstanding shares of common stock. Accordingly, he is able to exert significant control over our management and affairs requiring stockholder approval, including approval of significant corporate transactions. He may also be able to determine their compensation. Mr. Nakhwa also has significant influence in determining the outcome of any corporate transaction or other matters submitted to our shareholders for approval. This includes mergers and acquisitions, consolidations, and the sale of all or substantially all of our assets, election of directors and other significant corporate actions. In addition to his stock ownership, he is key to our operations and will have significant influence regarding our daily operation decisions. This concentration of ownership and influence over our decision-making may also discourage, delay, or prevent a change in control of the Company, which could deprive our other shareholders of an opportunity to receive a premium for their common stock as part of a sale of the Company and might reduce the price of our common stock.

Removed

We have requirements for and there is an uncertainty of access to additional capital.

Removed

Ultimately, our ability to continue our business operations depends in part on our ability to obtain financing through debt financing, equity financing, or commence operations and generate revenues or some combination of these or other means. There can be no assurance that we will be able to obtain any such financing.

Reworded

We have no cash flow from operations and dependare dependent on equityexternal financing and shareholder loans for our operations.financing.

Added

We currently generate no cash flow from operations and rely on equity financings and shareholder loans to fund our activities. Our existing capital resources are insufficient to complete our planned development and commercialization efforts. Failure to obtain additional funding could result in the suspension or termination of our business activities.

Added

Our management team is small, and the loss of key personnel could adversely affect our business.

Added

Our operations depend heavily on the continued services of our President and Chief Executive Officer, who devotes a portion of his time to our business and may have other professional obligations. The loss of his services, or our inability to attract and retain additional qualified personnel, could materially harm our development efforts and business prospects.

Added

Our controlling shareholder has significant voting power, which may not align with the interests of other shareholders.

Added

Our President and Chief Executive Officer beneficially owns a majority of our outstanding common stock and is able to exercise significant control over matters requiring stockholder approval, including the election of directors, approval of significant corporate transactions, and changes in management. This concentration of ownership may discourage or prevent a change in control and could limit other shareholders’ ability to influence corporate decisions.

Added

Our operating results may fluctuate significantly.

Added

Our future operating results may vary significantly due to numerous factors, many of which are beyond our control, including the timing and amount of operating expenses, availability of capital, regulatory developments, market acceptance of our technology, and general economic conditions. As a result, period-to-period comparisons may not be meaningful, and our operating results may fall below investor expectations.

Removed

Our current operating funds are less than necessary to complete our intended plan of operations. We will need additional funds. Our failure to obtain such additional financing could result in delay or indefinite postponement of further of any subsequent operations which would have a material adverse effect on our business.

Removed

Our operating results are likely to fluctuate significantly in the future due to a variety of factors, many of which we have no control over. Factors that may cause our operating results to fluctuate significantly include: our ability to generate enough working capital from future sales; the level of commercial acceptance by the public of the services/products we may develop; fluctuations in the demands of any products; the amount and timing operating costs and capital expenditures relating to expansion of subsequent business, operations, infrastructure, and general economic conditions. If realized, any of these factors could have a material effect on our business, financial condition, and operating results.

Reworded

The facial recognition industry is intenselyhighly competitivecompetitive, andrapidly evolving, and competitivesubject pressuresto couldchanging adverselypublic affect our pricing practices or demand for our offerings and services.perception.

Added

The facial recognition and biometric technology industry is characterized by rapid technological change, evolving standards, frequent product introductions, and intense competition. We compete with significantly larger, well-capitalized companies that have established brands, extensive customer relationships, and greater financial and technical resources.

Added

In addition, public and governmental attitudes toward facial recognition technology continue to evolve. Changes in social acceptance, political sentiment, or public policy could reduce demand for facial recognition solutions or restrict their deployment.

Added

Rapid technological change could render our technology obsolete or uncompetitive.

Added

Our success depends on our ability to continually develop and improve our technology to address evolving industry standards, regulatory requirements, and customer expectations. If we fail to adapt to technological advancements or competing solutions, our technology may become obsolete or commercially unattractive.

Added

Privacy laws, biometric regulations, and data protection requirements could limit adoption of our technology.

Added

The collection and use of biometric data are subject to increasing regulation in the United States and internationally. Existing and future laws governing data privacy, biometric information, artificial intelligence, and surveillance may impose additional compliance obligations, restrict the deployment of our technology, or increase our costs.

Added

Failure to comply with applicable laws and regulations could result in fines, penalties, litigation, reputational harm, or limitations on our ability to operate in certain jurisdictions.

Added

Ethical concerns, algorithmic bias, and misuse of facial recognition technology could adversely affect our business.

Added

Facial recognition technology raises ethical concerns, including the potential for algorithmic bias, inaccurate identification, and misuse in ways that may infringe individual rights. Failure to adequately address these concerns could result in reputational harm, regulatory scrutiny, reduced market acceptance, and loss of business opportunities.

Removed

We operate in the intensely competitive industry, which is characterized by rapidly changing technology, evolving industry standards and models for consuming and delivering business and services, frequent new product introductions, and frequent price and cost reductions. In general, as a participant in the facial recognition market, we face:

Removed

We may face competition from larger, more well-established competitors, which are well-capitalized companies with widespread distribution, brand recognition and penetration of platforms and service offerings. Our competitors include companies like Cognitec Systems, iProov, and Oosto, as well as Amazon, Microsoft, and McAfee. The significant purchasing and market power of these larger competitors, which have greater financial resources than we do, could allow them to surpass our market penetration and marketing efforts to promote and sell their offerings and services. In addition, many other companies participate in specific areas of our business, such as artificial intelligence, computer vision, biometric analysis, and neural networks . In some cases, we may partner with a company in one area of our business and compete with them in another. In delivering our FRT products to certain of our customers, we may partner with Amazon, Google, or Microsoft. The status of our business relationships with these companies can influence our ability to compete for opportunities. In addition, we see additional competition from both established and emerging vendors and providers. Failure to compete successfully with new or existing competitors in these and other areas could have a material adverse impact on our ability to generate additional revenues or sustain existing revenue levels.

Removed

Privacy concerns, evolving regulation of artificial intelligence, facial recognition and use of biometrics, and other domestic or foreign regulations may limit the use and adoption of our solutions and services and adversely affect our business.

Removed

Regulation related to the provision of services over involving AI, facial recognition and use of biometrics is evolving, as federal, state, and foreign governments continue to adopt new, or modify existing, laws and regulations addressing data privacy and the collection, processing, storage, transfer, and use of data. In some cases, new data privacy laws and regulations , such as the European Union’s General Data Protection Regulation that took effect in May 2018, the California Consumer Privacy Act, which took effect in January 2020, and an amended Act on the Protection of Personal Information in Japan, which took effect 2022, may impose new obligations on many of our customers, as well as directly on the Company as both a data controller and a data processor of human images and personal identifying information. These new laws may require us to make changes to our services and solutions to and/for our customers to comply with the new legal requirements and may also increase our potential liability exposure through higher potential penalties for non-compliance. ] These new or proposed laws and regulations are subject to differing interpretations and may be inconsistent among jurisdictions. These and other requirements could reduce demand for our services and solutions, require us to take on more onerous obligations in our contracts, restrict our ability to store, transfer and process data. In some cases, this could impact our ability to offer our services and solutions in certain locations or our customers' ability to deploy our solutions globally. Additionally, certain countries have passed or are considering passing laws requiring local data residency. The costs of compliance with and other burdens imposed by privacy laws, regulations and standards may limit the use and adoption of ,as well as reduce overall demand for our services and solutions, thereby,making it more difficult to meet expectations from or commitments to customers. This could lead to significant fines, penalties, or liabilities for noncompliance, or slow the pace at which we close sales transactions, any of which could harm our business.

Removed

In addition to government activity, privacy advocacy and other industry groups have established or may establish new self-regulatory standards that may place additional burdens on our ability to provide our services and solutions globally. Our customers expect us to meet voluntary certification and other standards established by third parties, such as related International Organization for Standardization standards. If we are unable to maintain these certifications or meet these standards, it could adversely affect our ability to provide our solutions to certain customers and could harm our business. Furthermore, concerns regarding data privacy may cause our customers’ customers to resist providing the data necessary to allow our customers to use our services and solutions effectively.

Removed

We will need continual development of our products to adapt to rapidly changing technology and consumer demands.

Removed

We will face intense competition in the marketplace and will be confronted by rapidly changing technology, evolving industry standards, and consumer preferences, regulatory changes, and the frequent introduction of new solutions by our competitors that we must adapt and respond to. We need to continuously update our technology we develop, including our machine learning and other proprietary algorithms, in order to attract and keep new clients and to stay in front of evolving industry standards and regulatory requirements. Our failure to adapt to a rapidly changing market conditions and accepted technology advances would adversely affect our business.

Removed

Our software is highly complex and may contain undetected errors.

Removed

The software underlying our platform is highly complex and may contain undetected errors or vulnerabilities, some of which may only be discovered after the code has been released. We anticipate relying heavily on a software engineering practice known as “continuous deployment,” meaning that we may release software code many times per day. This practice may result in the more frequent introduction of errors or vulnerabilities into the software underlying our platform. Any errors or vulnerabilities discovered in our code after release could result in damage to our reputation, loss of members, loss of revenue or liability for damages, any of which could adversely affect our growth prospects and our business.

Removed

We are subject to the terms of open-source licenses because our technology will incorporate open-source software.

Removed

The software powering our marketplace incorporates software covered by open-source licenses. In addition, we will likely regularly contribute source code to open-source software projects and release internal software projects under open-source licenses, and we anticipate doing so in the future. The terms of many open-source licenses have not been interpreted by U.S. courts and there is a risk that the licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to operate our marketplace. Under certain open-source licenses, we could be required to publicly release the source code of our software or to make our software available under open-source licenses. To avoid the public release of the affected portions of our source code, we could be required to expend substantial time and resources to re-engineer some or all of our software. In addition, use of open-source software can lead to greater risks than use of third-party commercial software because open-source licensors generally do not provide warranties or controls on the origin of the software. Use of open-source software may also present additional security risks because the public availability of such software may make it easier for hackers and other third parties to determine how to compromise our platform. Additionally, because any software source code we contribute to open-source projects is publicly available, our ability to protect our intellectual property rights in such software source code may be limited or lost entirely, and we will be unable to prevent our competitors or others from using such contributed software source code. Any of these risks could be difficult to eliminate or manage and, if not addressed, could adversely affect our business, financial condition, and results of operations.

Reworded

WeRISKS mayRELATED beTO unableOUR toTECHNOLOGY protectAND ourINTELLECTUAL intellectual property adequately.PROPERTY

Added

Our software is complex and may contain errors or vulnerabilities.

Added

Our technology is highly complex and may contain undetected errors, defects, or security vulnerabilities. Such issues could result in system failures, inaccurate outputs, data breaches, reputational damage, or liability, any of which could adversely affect our business and prospects.

Removed

Our intellectual property is an essential asset of our business. To establish and protect our intellectual property rights, we rely on a combination of trade secret, copyright, trademark and, to a lesser extent, patent laws, as well as confidentiality procedures and contractual provisions. The efforts we have taken to protect our intellectual property may not be sufficient or effective. We generally do not elect to register our copyrights or the majority of our trademarks, relying instead on the laws protecting unregistered intellectual property, which may not be sufficient. In addition, our copyrights, and trademarks, whether or not registered, and patents, may be held invalid or unenforceable if challenged. To the extent we do seek patent protection, any U.S. or other patents issued to us may not be sufficiently broad to protect our proprietary technologies. In addition, we may not be effective in policing unauthorized use of our intellectual property. Even if we do detect violations, we may need to engage in litigation to enforce our intellectual property rights. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive and could divert our management’s attention. In addition, our efforts may be met with defenses and counterclaims challenging the validity and enforceability of our intellectual property rights or may result in a court determining that our intellectual property rights are unenforceable. If we are unable to cost-effectively protect our intellectual property rights, then our business could be harmed.

Removed

We may be subject to intellectual property claims, which are extremely costly to defend, could require us to pay significant damages and could limit our ability to use certain technologies in the future.

Removed

Companies within the technology industries are frequently subject to litigation based on allegations of infringement or other violations of intellectual property rights. To the extent we gain greater public recognition, we may face a higher risk of being the subject of intellectual property claims. Third-party intellectual property rights may cover significant aspects of our technologies or business methods or block us from expanding our offerings. Any intellectual property claims against us, with or without merit, could be time consuming and expensive to settle or litigate and could divert the attention of our management. Litigation regarding intellectual property rights is inherently uncertain due to the complex issues involved, and we may not be successful in defending ourselves in such matters.

Removed

In addition, some of our competitors have extensive portfolios of issued patents. Many potential litigants, including some of our competitors and patent holding companies, have the ability to dedicate substantial resources to enforcing their intellectual property rights. Any claims successfully brought against us could subject us to significant liability for damages and we may be required to stop using technology or other intellectual property alleged to be in violation of a third party’s rights. We also might be required to seek a license for third-party intellectual property. Even if a license is available, we could be required to pay significant royalties or submit to unreasonable terms, which would increase our operating expenses. We may also be required to develop alternative non-infringing technology, which could require significant time and expense. If we cannot license or develop technology for any allegedly infringing aspect of our business, we would be forced to limit our service and may be unable to compete effectively. Any of these results could harm our business.

Removed

Ethical Use of AI in Facial Recognition.

Removed

The deployment of artificial intelligence, particularly in facial recognition technologies, presents significant ethical challenges that may adversely impact our operations and reputation. Key concerns include the potential for algorithmic bias, which can lead to inaccurate identification or profiling of individuals based on race, gender, or socioeconomic status. Such biases not only compromise the integrity of our technology but can also result in harmful societal consequences, including discrimination and wrongful arrests.

Removed

Additionally, the use of facial recognition raises serious privacy issues. Public and governmental scrutiny regarding surveillance practices has intensified, and improper use of our technology could lead to allegations of infringing on individual privacy rights. This may result in increased regulatory oversight and potential legal challenges, which could impose significant operational burdens and costs.

Removed

Moreover, failure to implement robust ethical guidelines and transparency in our AI practices could lead to reputational damage. Negative media coverage or backlash from civil rights organizations may erode consumer trust and confidence in our brand, ultimately affecting our market position and financial performance.

Removed

As we navigate these ethical considerations, any missteps in the responsible deployment of facial recognition technology could have lasting repercussions, including loss of partnerships, diminished market share, and potential fines or sanctions from regulatory bodies.

Showing the first 60 of 78 changed paragraphs. The complete comparison will be part of Pro (coming soon). Meanwhile you can read the full text in the original filing.

Management's Discussion & Analysis (MD&A) (10-K Item 7)

2new paragraphs
2removed paragraphs
2reworded paragraphs
789 → 786words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Reworded

Paragraph as it now reads, with added and removed wording marked:

Cash flows provided by financing activities during the year ended December 31, 20242025 amounted to $66,834,$205,797, as compared with cash provided of $70,301$66,834 for the year ended December 31, 2023.2024. Our positive financing cash flow for the year ended December 31, 2025 resulted from the sales of common stock and proceeds from notes payable. Our positive financing cash flow for the year ended December 31, 2024 resulted from proceeds from notes payable. Our positive financing cash flow for the year ended December 31, 2023 resulted from proceeds from related part notes.
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

Our other expenses for the year ended December 31, 2024,2025, consisted mainly of interest expense. Our other expenses for the year ended December 31, 2024 consisted mainly of interest expense netted against a gain on settlement of debt. Our other expenses for the year ended December 31, 2023 consisted mainly of interest expense and a loss on acquisition of assets.
see in full comparison
Removed text
“We recorded a net loss of $3,261,038 for the year ended December 31, 2024, as compared with a net loss of $1,733,722 for the year ended December 31, 2023.”
see in full comparison
New text
“We recorded a net loss of $207,485 for the year ended December 31, 2025, as compared with a net loss of $3,261,038 for the year ended December 31, 2024.”
see in full comparison
New text
“We had other expenses of $35,633 for the year ended December 31, 2025, as compared with other income of $36,820 for the year ended December 31, 2024.”
see in full comparison
Removed text
“We had other income of $36,820 for the year ended December 31, 2024, as compared with other expenses of 904,795 for the year ended December 31, 2023.”
see in full comparison
Full comparison: every changed paragraph (6)

Green = added, red = removed. Unchanged paragraphs, 6 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Added

We had other expenses of $35,633 for the year ended December 31, 2025, as compared with other income of $36,820 for the year ended December 31, 2024.

Removed

We had other income of $36,820 for the year ended December 31, 2024, as compared with other expenses of 904,795 for the year ended December 31, 2023.

Reworded

Our other expenses for the year ended December 31, 2024,2025, consisted mainly of interest expense. Our other expenses for the year ended December 31, 2024 consisted mainly of interest expense netted against a gain on settlement of debt. Our other expenses for the year ended December 31, 2023 consisted mainly of interest expense and a loss on acquisition of assets.

Added

We recorded a net loss of $207,485 for the year ended December 31, 2025, as compared with a net loss of $3,261,038 for the year ended December 31, 2024.

Removed

We recorded a net loss of $3,261,038 for the year ended December 31, 2024, as compared with a net loss of $1,733,722 for the year ended December 31, 2023.

Reworded

Cash flows provided by financing activities during the year ended December 31, 20242025 amounted to $66,834,$205,797, as compared with cash provided of $70,301$66,834 for the year ended December 31, 2023.2024. Our positive financing cash flow for the year ended December 31, 2025 resulted from the sales of common stock and proceeds from notes payable. Our positive financing cash flow for the year ended December 31, 2024 resulted from proceeds from notes payable. Our positive financing cash flow for the year ended December 31, 2023 resulted from proceeds from related part notes.

What changed in the latest 10-Q

Comparing 10-Q filed 2026-08-11 (period ending 2026-06-30) with 10-Q filed 2026-05-20 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

We could not find a separate Risk Factors item in the latest 10-Q. Some companies leave it out of quarterly reports; see the annual 10-K risk factors and the original filing. Open the filing on SEC.gov.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

14new paragraphs
17removed paragraphs
0reworded paragraphs
827 → 1,062words in section

New heading “We had no revenue for the three or six months ended June 30, 2026 and 2025”

Removed heading “Results of Operations for the Three Months Ended March 31, 2026 and 2025”

Removed heading “Other Income (Expenses)”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: going concern
“Going concern – The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $29,741,007 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to generate the necessary funds through licensing of its core products or the ability to raise additional capital through the future issuances of common stock or debt is unknown. …”
see in full comparison
Removed text topics: going concern
“Going concern – The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States (“GAAP”) on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During three months ended March 31, 2026, the Company incurred net losses of $52,813 and accumulated deficits of $29,653,599. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
see in full comparison
New text
“We had no revenue for the three or six months ended June 30, 2026 and 2025”
see in full comparison
Removed text
“Results of Operations for the Three Months Ended March 31, 2026 and 2025”
see in full comparison
Removed text
“Other Income (Expenses)”
see in full comparison
New text topics: artificial intelligence
“The Company continued development of its planned healthcare technology ecosystem, including artificial intelligence-powered clinical decision support applications, telehealth infrastructure, patient engagement technologies, healthcare analytics solutions, and related digital healthcare services intended for deployment throughout Latin America. In addition, the Company continued regulatory planning, strategic partnership discussions, and business development initiatives designed to support future commercial operations.”
see in full comparison
Full comparison: every changed paragraph (31)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Added

We had no revenue for the three or six months ended June 30, 2026 and 2025

Added

Operating expenses increased to $77,045 for the three months ended June 30, 2026, from $19,854 for the same period ended June 30, 2025. Operating expenses increased to $120,429 for the six months ended June 30, 2026, from $35,821 for the same period ended June 30, 2025. The increase in operating expenses is mainly the result of the increase in professional fees during the three and six month period.

Added

Other Expense

Added

We had other expense of $10,363 for the three months ended June 30, 2026, as compared with other expenses of $9,328 for the three months ended June 30, 2025. We had other expense of $19,792 for the six months ended June 30, 2026, as compared with other expenses of $17,816 for the six months ended June 30, 2025. Other expenses consisted of accrued interest expense and increased as a result of the Company issuing additional debt during 2026.

Added

We recorded a net loss of $87,408 for the three months ended June 30, 2026, as compared with a net loss of $29,182 for the three months ended June 30, 2025. We recorded a net loss of $140,221 for the six months ended June 30, 2026, as compared with a net loss of $33,783 for the six months ended June 30, 2025.The change in net income was the result of the factors described above.

Added

Going concern – The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred cumulative net losses of $29,741,007 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to generate the necessary funds through licensing of its core products or the ability to raise additional capital through the future issuances of common stock or debt is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. These factors, among others, raises substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

Added

As of June 30, 2026, we had total current assets in the amount of $0. Our total current liabilities as of June 30, 2026 were $771,081. We had a working capital deficit of $771,081 as of June 30, 2026, compared with a working capital deficit of $630,860 as of December 31, 2025.

Added

Operating activities used $83,418 in cash for the six months ended June 30, 2026, as compared with $33,869 used for the six months ended June 30, 2025. Our negative operating cash flows for 2026 and 2025 were largely the result of our net loss for those quarters, mainly offset by changes in operating assets and liabilities and the amortization of debt discount and amortization.

Added

Cash flow provided from financing activities was $83,418 for the six months ended June 30, 2026, as compared with $33,869 provided by cash flows for financing activities during the six months ended June 30, 2025. Our debt from financing activities consist of the issuance of notes payable.

Added

During the six months ended June 30, 2026, the Company continued executing its strategy of developing an artificial intelligence-enabled digital healthcare platform focused on Latin America. Management continued the integration and evaluation of the intellectual property acquired during the first quarter of 2026 and advanced the Company's organizational and operational infrastructure to support future commercialization.

Added

The Company continued development of its planned healthcare technology ecosystem, including artificial intelligence-powered clinical decision support applications, telehealth infrastructure, patient engagement technologies, healthcare analytics solutions, and related digital healthcare services intended for deployment throughout Latin America. In addition, the Company continued regulatory planning, strategic partnership discussions, and business development initiatives designed to support future commercial operations.

Added

The Company's wholly owned Venezuelan subsidiary, Inversiones Long 33, C.A., continues to serve as the Company's primary operating platform in Venezuela. During the quarter, management continued organizational development, technology integration activities, regulatory planning, and preparations for the future commercialization of the Company's healthcare solutions.

Added

During the quarter, the Company completed its corporate rebranding to LataMed AI Corp. and continued expanding its healthcare technology strategy through business development initiatives, strategic planning, and industry engagement activities intended to increase the Company's visibility and support future commercial growth throughout Latin America. The Company also continued evaluating opportunities to expand its presence into additional international healthcare markets.

Added

Although the Company has not yet generated revenue from these initiatives, management believes meaningful progress has been made toward establishing the operational and regulatory foundation necessary for commercialization. The Company intends to continue expanding its technology platform, pursuing strategic relationships, and advancing regulatory initiatives as it works toward the commercial deployment of its digital healthcare ecosystem.

Removed

During the quarter ended March 31, 2026, the Company undertook a strategic transition toward the development of artificial intelligence-enabled healthcare technology solutions and related healthcare services infrastructure focused on Latin America.

Removed

On February 17, 2026, the Company entered into an Asset Purchase Agreement pursuant to which it acquired certain proprietary healthcare technology assets and intellectual property relating to an artificial intelligence-enabled healthcare analytics platform and a technology-enabled healthcare services coordination platform. The acquired assets include technologies intended to support data-driven healthcare analytics, patient monitoring, telehealth infrastructure, and related healthcare applications.

Removed

In connection with the Company’s strategic transition, the Company also established and organized operations through its wholly-owned Venezuelan subsidiary, Inversiones Long 33, C.A., which is intended to serve as the Company’s operating entity in Venezuela and support its broader Latin American business strategy.

Removed

During April 2026, certain intellectual property assets acquired by the Company were assigned to the subsidiary as part of an internal operational reorganization. Prior to such assignment, the subsidiary had no material operations, assets, liabilities, or standalone financial history.

Removed

Current activities are focused on organizational development, operational structuring, technology evaluation, regulatory planning, and business development initiatives related to the Company’s intended healthcare technology platform and services model.

Removed

Results of Operations for the Three Months Ended March 31, 2026 and 2025

Removed

We had no revenue for three months ended March 31, 2026 and 2025.

Removed

Operating expenses increased to $43,384 for the three months ended March 31, 2026, from $15,967 for the same period ended March 31, 2025.

Removed

The increase in operating expenses is the result of additional professional fees incurred during the three months ended March 31, 2026.

Removed

Other Income (Expenses)

Removed

We had other expenses of $9,429 for the three months ended March 31, 2026, as compared with other expenses of $8,488 for the three months ended March 31, 2025. The increase in other expenses is the result of increased interest expense incurred during the three months ended March 31, 2026.

Removed

We recorded a net loss of $52,813 for the three months ended March 31, 2026, as compared with a net loss of $24,455 for the three months ended March 31, 2025.

Removed

Going concern – The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States (“GAAP”) on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During three months ended March 31, 2026, the Company incurred net losses of $52,813 and accumulated deficits of $29,653,599. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

Removed

As of March 31, 2026, we had total current assets of $0 and total assets in the amount of $7,824,000. Our total current liabilities as of March 31, 2026 were $683,673. We had a working capital deficit of $683,673 as of March 31, 2026, compared with a working capital deficit of $630,860 as of December 31, 2025.

Removed

Operating activities used $28,384 in cash for the three months ended March 31, 2026, as compared with $19,015 used for the three months ended March 31, 2025. Our negative operating cash flows for 2026 and 2025 was largely the result of our net loss for those quarters, mainly offset by changes in operating assets and liabilities.

Removed

We used no cash in investing activities for the three months ended March 31, 2026 and 2025.

Removed

Cash flow provided from financing activities was $28,384 for the three months ended March 31, 2026, as compared with $19,015 provided by cash flows for financing activities during the three months ended March 31, 2025.

LMED insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

No Form 4 stock transactions in this period.

Well-known investors holding LMED (13F)

None of the 59 investors we track reported a position in their latest 13F.

Coming soon: email alerts when LMED files, watchlists and downloadable comparisons.